Advertisement

Assessment of apheresis platelets during 5 days of storage: A National Cancer Institute, Cairo University experience

Published:November 25, 2021DOI:https://doi.org/10.1016/j.transci.2021.103327

      Abstract

      Background

      Platelet transfusion therapy is widely used to prevent hemorrhage in patients with thrombocytopenia and platelet disorders. The platelet concentrate (PC) quality is affected by increased storage time, as reflected in the decreased number of platelets, morphological changes, and impaired functions. This study aimed to analyze the impact of 5 days storage on platelets count and the expression of CD63, and Annexin V as activation markers during PC storage.

      Methods

      Fifty PCs collected from single donors were tested for platelet count on days 0, 3, and 5 using a Sysmex blood counter. CD61, CD63, and Annexin V expression was analyzed by a multicolor Navios flow cytometer.

      Results

      There was a significant decrease in platelet count during 5 days of storage. There was a direct relationship between storage time and degree of platelet activation. CD63 had almost double increased expression on day 5 than day 3. Annexin V showed significantly increased expression on day 3 with minor differences between days 3 and 5.

      Conclusion

      According to standard blood bank conditions, PC stored for 5 days showed a degree of in vitro activation as evidenced by CD63 and Annexin V expression, may lead to reduced therapeutic efficacy. Flow cytometry monitoring platelet activation in PC offers a better understanding of the changes during PC storage and may help improve platelet products.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stroncek D.F.
        • Rebulla P.
        Platelet transfusions.
        Lancet. 2007; 370: 427-438https://doi.org/10.1016/S0140-6736(07)61198-2
        • Bashir J.
        • Panero A.J.
        • Sherman A.L.
        The emerging use of platelet rich plasma in musculoskeletal medicine.
        J Am Osteopath Assoc. 2015; 115: 24-31https://doi.org/10.7556/jaoa.2015.004
        • San Sebastian K.M.
        • Lobato I.
        • Hernández I.
        • Burgos-Alonso N.
        • Gomez-Fernandez M.C.
        • López J.L.
        • et al.
        Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: phase III study.
        BMC Fam Pract. 2014; 15: 211https://doi.org/10.1186/s12875-014-0211-8
        • Shams Hakimi C.
        • Hesse C.
        • Wallén H.
        • Boulund F.
        • Grahn A.
        • Jeppsson A.
        In vitro assessment of platelet concentrates with multiple electrode aggregometry.
        Platelets. 2015; 26: 132-137https://doi.org/10.3109/09537104.2014.898141
        • Shrivastava M.
        The platelet storage lesion.
        Transfus Apher Sci. 2009; 41: 105-113https://doi.org/10.1016/j.transci.2009.07.002
        • Garraud O.
        • Cognasse F.
        • Tissot J.D.
        • Chavarin P.
        • Laperche S.
        • Morel P.
        • et al.
        Improving platelet transfusion safety: biomedical and technical considerations.
        Blood Transfus. 2016; 14: 109-122https://doi.org/10.2450/2015.0042-15
        • AuBuchon J.P.
        • Herschel L.
        • Roger J.
        • Murphy S.
        Preliminary validation of a new standard of efficacy for stored platelets.
        Transfusion. 2004; 44: 36-41https://doi.org/10.1046/j.0041-1132.2004.00604.x
        • Tynngård N.
        Preparation, storage and quality control of platelet concentrates.
        Transfus Apher Sci. 2009; 41: 97-104https://doi.org/10.1016/j.transci.2009.07.001
        • van der Meer P.F.
        Platelet concentrates, from whole blood or collected by apheresis?.
        Transfus Apher Sci. 2013; 48: 129-131https://doi.org/10.1016/j.transci.2013.02.004
        • Gardiner E.E.
        • Andrews R.K.
        Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI.
        Transfus Med Rev. 2014; 28: 56-60https://doi.org/10.1016/j.tmrv.2014.03.001
        • Feys H.B.
        • Coene J.
        • Devloo R.
        • Van Aelst B.
        • Pottel H.
        • Vandekerckhove P.
        • Compernolle V.
        Persistent aggregates in apheresis platelet concentrates.
        Vox Sang. 2015; 108: 368-377https://doi.org/10.1111/vox.12243
        • Pakala R.
        • Waksman R.
        Currently available methods for platelet function analysis: advantages and disadvantages.
        Cardiovasc Revasc Med. 2011; 12: 312-322https://doi.org/10.1016/j.carrev.2010.09.005
        • Smyth S.S.
        • et al.
        Platelet structure and function in hemostasis and thrombosis.
        in: Greer J.P. Arber D.A. Glader B. Wintrobe’s Wintrobe’s clinical hematology. 13th ed. Philadelphia: Lippincott Williams & Wilkins, a Wolters Kluwer business, 2014: 389-410
        • Michelson A.D.
        • Barnard M.R.
        • Krueger L.A.
        • Frelinger A.L.
        • Furman M.I.
        Evaluation of platelet function by flow cytometry.
        Methods. 2000; 21: 259-270https://doi.org/10.1006/meth.2000.1006
        • Wang C.
        • Mody M.
        • Herst R.
        • Sher G.
        • Freedman J.
        Flow cytometric analysis of platelet function in stored platelet concentrates.
        Transfus Sci. 1999; 20: 129-139https://doi.org/10.1016/s0955-3886(99)00022-3
        • Metcalfe P.
        • Williamson L.M.
        • Reutelingsperger C.P.
        • Swann I.
        • Ouwehand W.H.
        • Goodall A.H.
        Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
        Br J Haematol. 1997; 98: 86-95https://doi.org/10.1046/j.1365-2141.1997.1572983.x
        • Tynngård N.
        • Wallstedt M.
        • Södergren A.L.
        • Faxälv L.
        • Ramström S.
        Platelet adhesion changes during storage studied with a novel method using flow cytometry and protein-coated beads.
        Platelets. 2015; 26: 177-185https://doi.org/10.3109/09537104.2014.891728
        • Shams Hakimi C.
        • Hesse C.
        • Wallén H.
        • Boulund F.
        • Grahn A.
        • Jeppsson A.
        In-vitro assessment of platelet concentrates with multiple electrode aggregometry.
        Platelets. 2015; 26: 132-137https://doi.org/10.3109/09537104.2014.898141
        • Gyulkhandanyan A.V.
        • Mutlu A.
        • Freedman J.
        • Leytin V.
        Selective triggering of platelet apoptosis, platelet activation or both.
        Br J Haematol. 2013; 161: 245-254https://doi.org/10.1111/bjh.12237
        • Tait J.F.
        • Smith C.
        • Wood B.L.
        Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V.
        Blood Cells Mol Dis. 1999; 25 (Oct-Dec; PMID: 10744422): 271-278https://doi.org/10.1006/bcmd.1999.0254
        • Albanyan A.M.
        • Murphy M.F.
        • Rasmussen J.T.
        • Heegaard C.W.
        • Harrison P.
        Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V.
        Transfusion. 2009; 49: 99-107https://doi.org/10.1111/j.1537-2995.2008.01933.x
        • Hagberg I.A.
        • Lyberg T.
        Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies.
        Platelets. 2000; 11: 137-150https://doi.org/10.1080/095371000403071
        • Dijkstra-Tiekstra M.J.
        • Pietersz R.N.
        • Huijgens P.C.
        Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
        Vox Sang. 2004; 87: 257-263https://doi.org/10.1111/j.1423-0410.2004.00573.x
        • Dowling M.R.
        • Josefsson E.C.
        • Henley K.J.
        • Hodgkin P.D.
        • Kile B.T.
        Platelet senescence is regulated by an internal timer, not damage inflicted by hits.
        Blood. 2010; 116: 1776-1778https://doi.org/10.1182/blood-2009-12-259663
        • Di Pumpo M.
        • Noris P.
        • Pecci A.
        • Savoia A.
        • Seri M.
        • Ceresa I.F.
        • Balduini C.L.
        Defective expression of GPIb/IX/V complex in platelets from patients with May Hegglin anomaly and Sebastian syndrome.
        Haematologica. 2002; 87: 943-947
        • Singh S.
        • Shams Hakimi C.
        • Jeppsson A.
        • Hesse C.
        Platelet storage lesion in interim platelet unit concentrates: a comparison with buffy-coat and apheresis concentrates.
        Transfus Apher Sci. 2017; 56: 870-874https://doi.org/10.1016/j.transci.2017.10.004
        • Hosseini E.
        • Ghasemzadeh M.
        • Atashibarg M.
        • Haghshenas M.
        ROS scavenger, N-acetyl-l-cysteine and NOX specific inhibitor, VAS2870 reduces platelets apoptosis while enhancing their viability during storage.
        Transfusion. 2019; 59: 1333-1343https://doi.org/10.1111/trf.15114
        • Reddoch K.M.
        • Pidcoke H.F.
        • Montgomery R.K.
        • Fedyk C.G.
        • Aden J.K.
        • Ramasubramanian A.K.
        • et al.
        Hemostatic function of apheresis platelets stored at 4°C and 22°C.
        Shock. 2014; 41: 54-61https://doi.org/10.1097/SHK.0000000000000082
        • Hosseini E.
        • Beshkar P.
        • Ghasemzadeh M.
        Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage.
        J Thromb Thrombolysis. 2018; 46 (PMID: 30218271): 534-540https://doi.org/10.1007/s11239-018-1739-6
        • Escolar G.
        • McCullough J.
        Platelet in vitro assays: their correspondence with their in vivo hemostatic potential.
        Transfusion. 2019; 59: 3783-3793https://doi.org/10.1111/trf.15559
        • Vučetić D.
        • Ilić V.
        • Vojvodić D.
        • Subota V.
        • Todorović M.
        • Balint B.
        Flow cytometry analysis of platelet populations: usefulness for monitoring the storage lesion in pooled buffy-coat platelet concentrates.
        Blood Transfus. 2018; 16: 83-92https://doi.org/10.2450/2016.0193-16
        • van Velzen J.F.
        • Laros-van Gorkom B.A.
        • Pop G.A.
        • van Heerde W.L.
        Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.
        Thromb Res. 2012; 130: 92-98https://doi.org/10.1016/j.thromres.2012.02.041
        • Södergren A.L.
        • Tynngård N.
        • Berlin G.
        • Ramström S.
        Responsiveness of platelets during storage studied with flow cytometry formation of platelet subpopulations and LAMP-1 as new markers for the platelet storage lesion.
        Vox Sang. 2016; 110: 116-125https://doi.org/10.1111/vox.12324
        • Handtke S.
        • Steil L.
        • Greinacher A.
        • Thiele T.
        Toward the relevance of platelet subpopulations for transfusion medicine.
        Front Med (Lausanne). 2018; 5: 17https://doi.org/10.3389/fmed.2018.00017
        • Lesyk G.
        • Jurasz P.
        Advances in platelet subpopulation research.
        Front Cardiovasc Med. 2019; 6 (PMID: 31572733; PMCID: PMC6753372): 138https://doi.org/10.3389/fcvm.2019.00138
        • Burnouf T.
        • Chou M.L.
        • Goubran H.A.
        • Cognasse F.
        • Garaud O.
        • Seghatchian J.
        An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful?.
        Transfus Apher Sci. 2015; 53: 137-145